Skip to content

Construction and Application of Tumor Full-cycle Prevention and Treatment System Based on Traditional Chinese Medicine Thinking: A Randomized Controlled Clinical Study of Hezhongxiaopi Granules in the Treatment of Gastric Precancerous Lesions

Construction and Application of Tumor Full-cycle Prevention and Treatment System Based on Traditional Chinese Medicine Thinking: A Randomized Controlled Clinical Study of Hezhongxiaopi Granules in the Treatment of Gastric Precancerous Lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086344
Enrollment
Unknown
Registered
2024-06-28
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric precancerous lesion

Interventions

Treatment group:Hezhongxiaopi granule
Treatment group:Stomach FuChun Capsules

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?Meet the Western medical diagnostic criteria of GPL and the diagnostic criteria of TCM spleen deficiency and dampness obstruction, stasis and toxicity interconnection certificate; ? Age from 18 to 80 years old; ?Patients with good compliance, voluntary and able to cooperate with the treatment, and sign the informed consent.

Exclusion criteria

Exclusion criteria: ?Pregnant or lactating women; ?Patients with serious diseases of important organs (such as heart, brain, lungs, liver, kidneys) and unable to tolerate gastroscopy; ?Those who have been confirmed by gastroscopy and pathological examination to be cancerous, or GPL with duodenal ulcer, gastric ulcer, and history of upper gastrointestinal surgery; ?Liver and kidney function tests were performed and the results were abnormal and clinically significant; ?Mental and legal disability patients; ?Patients were suspected or determined a history of alcohol and drug abuse, or with other lesions that may reduce the possibility of participation or complicate the group; ?Patients who are allergic to the drugs of study.

Design outcomes

Primary

MeasureTime frame
Pathologic and histologic changes in the gastric mucosa;

Secondary

MeasureTime frame
TCM Symptom Score;Survival quality;

Countries

China

Contacts

Public ContactLiu Zhen

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

doctorliuzhen@126.com+86 135 8155 3766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026